comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 15:38:51 - browse：45468

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Poor hospice wound care hurts patients and families

WSS

Here's how to stay safe from wildfire smoke amid reduced air quality

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Here's how to stay safe from wildfire smoke amid reduced air quality

leisure time

comprehensive

knowledge

In Memoriam: Notable people who died in 2023

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Medicare details structure of new drug price negotiation program

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

The high cost of giving birth even with insurance

CRISPR pioneers react to Casgevy, first gene

Drug repurposing or repositioning? The language matters

Medical experts exlpore how to eliminate bias in clinical algorithms

23andMe had bad news about my health. I wish a person had delivered it

Why do we get seasonal allergies?

leisure time

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Hospitals look to new technology to keep health care workers safe

NYU radiologists take on the challenge of expensive MRI machines

Illumina to lay off 10% of research and development team

leisure time

Wikipedia

hotspot

hotspot